ClinicalTrials.Veeva

Menu

Neural Mechanisms Underlying Alcohol Induced Disinhibition

T

Technische Universität Dresden

Status

Completed

Conditions

Alcoholism

Treatments

Drug: Ethanol
Drug: Placebo - half-normal saline

Study type

Observational

Funder types

Other

Identifiers

NCT01097213
U01 AA017900 SA2

Details and patient eligibility

About

Forty 18-year-old social drinkers will be selected from the sample tested in specific aim 1 ("Prospective Assessment of Adolescent Drinking Trajectories With Computer-Assisted Self-administration of Ethanol (CASE)"; ClinicalTrials.gov identifier: NCT01063166). The functional magnetic resonance imaging blood-oxygen-level-dependent (fMRI BOLD) activity related to disinhibition measured with the Stop Signal task will be assessed during a continuous infusion of alcohol, clamping the arterial Breath Alcohol Concentration (aBAC) at 60 mg% for approximately one hour. It will be examined whether this fMRI BOLD activity is associated with the initial drinking trajectories and the alcohol consumption at age 18 and at age 20 identified in specific aim 1. Furthermore, fMRI will be used with the Taylor Aggression Paradigm to determine which brain areas mediate increased physical aggression during the same continuous infusion of alcohol as described above. All participants will undergo an alcohol and a placebo fMRI session.

Enrollment

50 patients

Sex

All

Ages

18 to 19 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • male and female Caucasian volunteers aged 18 years/0 months to 19 years/11 months;
  • written informed consent by the subject;
  • habitual social drinking during the two months preceding participation, defined by at least one drinking day in any two weeks-interval;
  • at least one prior experience of alcohol intoxication
  • being able to abstain from tobacco use for four hours without developing nicotine withdrawal symptoms;
  • effective contraception in female participants;
  • consenting to abstain from any illegal substance use for 2 weeks prior to participation;
  • living within 15 km (9.5 miles) from downtown Dresden;
  • sufficient information concerning alcohol use in both parents and in at least four second-degree relatives

Exclusion criteria

  • prior medical treatment due to alcohol use;
  • current or prior history of any serious disease, including CNS, cardiovascular, respiratory, gastrointestinal, hepatic, renal, endocrine, alcohol or drug dependence, but not alcohol abuse;
  • current history of Axis-I psychiatric illness, including premenstrual dysphoric disorder;
  • current or prior history of alcohol-induced flushing reactions;
  • positive urine screen for cannabinoids, cocaine, amphetamines, opiates, or benzodiazepines;
  • light or non-drinkers: averaging less than 2 standard drinks per week in the preceding two months;
  • intention to become pregnant
  • pregnancy or positive urine pregnancy screening or breast-feeding;
  • any alcohol intake on the test day or the day before;
  • use of medications known to interact with alcohol within 2 weeks of the study;
  • positive hepatitis or HIV at screening, provided the subject consented to these tests
  • any conditions posing safety issues with the fMRI scan, such as ferromagnetic implants, cardiac pacemakers or insulin pumps

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems